Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 9;7(2):21.
doi: 10.3390/diagnostics7020021.

Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer

Affiliations
Review

Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer

Haafsa Arshad Sahibzada et al. Diagnostics (Basel). .

Abstract

Saliva has been useful as a liquid biopsy for the diagnosis of various oral or systemic diseases, and oral squamous cell carcinoma (OSCC) is no exception. While its early detection and prevention is important, salivary cytokines expression, specifically of Interleukin-8 (IL-8), Interleukin-6 (IL-6) and Tumor necrosis factor (TNF-α), does contribute to the pathogenesis of cancer and these cytokines serve as potential biomarkers. Their excessive production plays a role in cancer progression and establishment of angiogenesis. However, other inflammatory or immunological conditions may affect the levels of cytokines in saliva. This article reviews the expression of levels of specific cytokines i.e., IL-8, IL-6 and TNF-α, their signaling pathways in the development of oral cancer, and how they are essential for the diagnosis of OSCC and updates related to it. Apart from serum, the saliva-based test can be a cost-effective tool in the follow-up and diagnosis of OSCC. Moreover, large-scale investigations are still needed for the validation of salivary cytokines.

Keywords: biomarker; biopsy; cancer and salivaomics; interleukin-6; interleukin-8; saliva; tumor necrosis factor-α (TNF-α).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Classification of cytokines. IL = Interleukin; TNF = Tumor necrosis factor; IFN = Interferon; TGF = Transforming growth factor; TRAIL = TNF-related apoptosis inducing ligand; LIGHT = homologous to Lymphotoxin, exhibits Inducible expression and completes with HSV Glycoprotien D for binding to Herpesvirus entry mediator, a receptor expressed on T-lymphocytes; CC, CXC = conserved cysteine residues and chemokines; IFNC = Interferon-C.
Figure 2
Figure 2
A schematic diagram illustrates the activation of IL-8, IL-6 and TNF-α through activated macrophages and the range of their signalling pathways in tumor microenvironments.
Figure 3
Figure 3
Pathways involved in activation and release of IL-8 and their effects at cellular level.

References

    1. Baig M.S., Bhutto R.A., Muhammad S., Siddiqui M.I. Epidemiology of oral cancer in Southern Punjab, Pakistan. Pak. J. Med. Heal. Sci. 2015;9:1269–1271.
    1. Ford P.J., Farah C.S. Early detection and diagnosis of oral cancer: Strategies for improvement. J. Cancer Policy. 2013;1:e2–e7. doi: 10.1016/j.jcpo.2013.04.002. - DOI
    1. Kalavrezos N., Scully C. Mouth Cancer for Clinicians Part 7: Cancer Diagnosis and Pre-treatment Preparation. Dent. Update. 2016;43:50–54, 57–60 & 63–65. - PubMed
    1. Zhang Y., Sun J., Lin C.-C., Abemayor E., Wang M.B., Wong D.T.W. The emerging landscape of salivary diagnostics. Periodontol 2000. 2016;70:38–52. doi: 10.1111/prd.12099. - DOI - PubMed
    1. Gstaiger M., Aebersold R. Applying mass spectrometry-based proteomics to genetics, genomics and network biology. Nat. Rev. Genet. 2009;10:617–627. doi: 10.1038/nrg2633. - DOI - PubMed

LinkOut - more resources